2005
DOI: 10.1523/jneurosci.1517-05.2005
|View full text |Cite
|
Sign up to set email alerts
|

Constitutively Active Cytoplasmic c-Jun N-Terminal Kinase 1 Is a Dominant Regulator of Dendritic Architecture: Role of Microtubule-Associated Protein 2 as an Effector

Abstract: Normal functioning of the nervous system requires precise regulation of dendritic shape and synaptic connectivity. Here, we report a severe impairment of dendritic structures in the cerebellum and motor cortex of c-Jun N-terminal kinase 1 (JNK1)-deficient mice. Using an unbiased screen for candidate mediators, we identify the dendrite-specific high-molecular-weight microtubule-associated protein 2 (MAP2) as a JNK substrate in the brain. We subsequently show that MAP2 is phosphorylated by JNK in intact cells an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

17
192
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 162 publications
(211 citation statements)
references
References 62 publications
17
192
0
Order By: Relevance
“…Among all post-translational modifications of MAP2, phosphorylation is probably the most relevant to extracellular signals (for review, see Sánchez et al, 2000). MAP2 has been found to be a substrate for many protein kinases and phosphatases, including c-Jun N-terminal kinase1 (JNK1) and stathmin, whose phosphorylations of MAPs are important in defining neuronal dendritic structure (Björkblom et al, 2005;Ohkawa et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…Among all post-translational modifications of MAP2, phosphorylation is probably the most relevant to extracellular signals (for review, see Sánchez et al, 2000). MAP2 has been found to be a substrate for many protein kinases and phosphatases, including c-Jun N-terminal kinase1 (JNK1) and stathmin, whose phosphorylations of MAPs are important in defining neuronal dendritic structure (Björkblom et al, 2005;Ohkawa et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…However, sustained and systemic JNK inhibition may cause various adverse side effects, because JNK also have other important functions in the development, differentiation, and insulin resistance (Figure 7b) (Waetzig and Herdegen, 2005). For example, JNK1 À/À mice showed severe impairment in the architecture of the brain, indicating that JNK phosphorylates microtubuleassociated proteins and contributes to normal brain functions (Chang et al, 2003;Bjorkblom et al, 2005). Therefore, Waetzig and Herdegen (2005) proposed the context-specific inhibition of JNK, that is, specific inhibition of damaging actions of JNK.…”
Section: Discussionmentioning
confidence: 99%
“…The actin depolymerizers Cyt.D (1 mM) and Lat.A (1 mM) were obtained from Calbiochem (San Diego, CA, USA). [9, H] palmitic acid (57 Ci/mmol) and biotin (Btn)-BMCC were purchased from PerkinElmer Life Sciences (Waltham, MA, USA). Optiprep was purchased from Axis Shield (Dundee, Scotland).…”
Section: Methodsmentioning
confidence: 99%
“…[3][4][5][6] However, accumulating evidence supports a physiological role of JNK in regulating neurite formation and morphogenesis. [7][8][9][10][11][12] Pharmacological inhibition of JNK activity blocks axogenesis in hippocampal neurons, arguing for an essential role of JNK in neurite development. 13 Growth factors and signalling molecules, including secreted proteins of the Wnt family, have also been found to activate JNK for remodelling dendrites and axons, a process that relies on cytoskeletal rearrangement.…”
mentioning
confidence: 99%